SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTEG- Bloodless Glucose Monitor

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Don Savage who wrote ()9/24/1996 1:55:00 AM
From: Don Savage   of 176
 
Integ's initial public offering of three million shares priced at 9-1/2 on Wednesday afternoon June 26th 1996 the company started
trading about an hour before close. The offering priced below the estimated price range of $10-11 per share, which was down from an initial price range of $12-14 per share. Integ is developing a painless hand-held glucose monitoring product for use by people with diabetes.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext